We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESSA
2826
DELISTED
ESSA Bancorp
ESSA
$12.6K ﹤0.01%
718
– –
CRD.A icon
2827
Crawford & Co Class A
CRD.A
$632M
$12.6K ﹤0.01%
1,459
– –
OPRX icon
2828
OptimizeRx
OPRX
$165M
$12.6K ﹤0.01%
1,258
– –
ATLC icon
2829
Atlanticus Holdings
ATLC
$1.47B
$12.6K ﹤0.01%
446
– –
VRCA icon
2830
Verrica Pharmaceuticals
VRCA
$83.5M
$12.6K ﹤0.01%
172
– –
SLDB icon
2831
Solid Biosciences
SLDB
$974M
$12.5K ﹤0.01%
+2,206
New +$19.8K
PESI icon
2832
Perma-Fix Environmental Services
PESI
$381M
$12.5K ﹤0.01%
+1,232
New +$13.7K
BNDX icon
2833
Vanguard Total International Bond ETF
BNDX
$83B
$12.5K ﹤0.01%
256
– –
FBLG icon
2834
FibroBiologics
FBLG
$7.66M
$12.4K ﹤0.01%
+125
New +$23.8K
GOEV
2835
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$12.4K ﹤0.01%
+291
New +$14.2K
STHO icon
2836
Star Holdings Shares of Beneficial Interest
STHO
$117M
$12.4K ﹤0.01%
1,028
– –
KYTX icon
2837
Kyverna Therapeutics
KYTX
$500M
$12.4K ﹤0.01%
+1,649
New +$25.2K
CRBU icon
2838
Caribou Biosciences
CRBU
$160M
$12.3K ﹤0.01%
7,487
– –
FVCB icon
2839
FVCBankcorp
FVCB
$339M
$12.2K ﹤0.01%
1,120
– –
SMID icon
2840
Smith-Midland
SMID
$147M
$12.2K ﹤0.01%
+440
New +$16.1K
MDWD icon
2841
MediWound
MDWD
$174M
$12.2K ﹤0.01%
+785
New +$13K
ALCO icon
2842
Alico
ALCO
$304M
$12.2K ﹤0.01%
470
– –
RIGL icon
2843
Rigel Pharmaceuticals
RIGL
$762M
$12.2K ﹤0.01%
1,481
– –
LCNB icon
2844
LCNB Corp
LCNB
$285M
$12.1K ﹤0.01%
873
– –
RSVR
2845
Reservoir Media
RSVR
$656M
$12.1K ﹤0.01%
1,534
– –
INBX icon
2846
Inhibrx
INBX
$1.42B
$12.1K ﹤0.01%
+853
New +$13.3K
VEL icon
2847
Velocity Financial
VEL
$715M
$12K ﹤0.01%
672
– –
AEYE icon
2848
AudioEye
AEYE
$72.6M
$12K ﹤0.01%
+684
New +$12.1K
CADL icon
2849
Candel Therapeutics
CADL
$865M
$12K ﹤0.01%
+1,941
New +$14.6K
SSTI icon
2850
SoundThinking
SSTI
$107M
$12K ﹤0.01%
986
– –
112 113
114
115 116

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.